Africa News Observer: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa News Observer.

Press releases published on June 3, 2026

Jun. 3, 2026

Kenya Launches Strategic Block Trades Channel to Mobilise Global Capital via Discounted Bulk Shares

Indeterminate EIN Presswire

Jun. 3, 2026

AFRIDEX Unveils One of the World’s Most Operationally Immersive Defence Exhibition Environments

Indeterminate EIN Presswire

Jun. 3, 2026

Why Do Sanitary Brand Suppliers Partner with China Leading Cast Film Machine provider for High-Speed PE Production?

Indeterminate EIN Presswire

Jun. 3, 2026

Alamar Biosciences实现居家指尖采血样本适配超高灵敏度多重蛋白质组学检测

Indeterminate GlobeNewswire

Jun. 3, 2026

Alamar Biosciences 讓家居採集的指尖血液樣本，可用於靈敏度極高的多重蛋白質體分析

Indeterminate GlobeNewswire

Jun. 3, 2026

XS.com Expande Equipe de Liderança com a Nomeação de Giannis Kontogiannis como Head de Funding

Indeterminate EIN Presswire

Jun. 3, 2026

Edge Copper Announces Terms of C$20.3 Million Overnight Marketed Public Offering and Concurrent Non-Brokered Private Placement

Indeterminate GlobeNewswire

Jun. 3, 2026

Skyriss Explains Why Spreads, Slippage and Execution Quality Matter for Forex and CFD Traders in 2026

Indeterminate GlobeNewswire

Jun. 3, 2026

Emperor Reports Deep Wide High-Grade Gold Intercept on the Duquesne West Property Under Option from Globex

Indeterminate GlobeNewswire

Jun. 3, 2026

Sparrow Pharmaceuticals Announces Acceptance of Late-Breaking Presentation of Interim Part 1 Results from CAPTAIN-T2D at the Endocrine Society (ENDO) 2026 Annual Meeting

Indeterminate GlobeNewswire

Jun. 3, 2026

LIXTE Biotechnology Announces $16,566,027 Registered Direct Offering Priced at the Market Under Nasdaq Rules, Strengthening Balance Sheet for Next Phase of Strategic Growth

Indeterminate GlobeNewswire

Jun. 3, 2026

Sapu Nano Expands International Development of Sapu003 and Appoints Global Clinical Trials (GCT) as Lead CRO for Phase 1b Program

Indeterminate GlobeNewswire

Jun. 3, 2026

Liminatus Pharma Enters Into Warrant Exercise Transaction for $1.9 Million in Gross Proceeds

Indeterminate GlobeNewswire

Jun. 3, 2026

Kyverna Therapeutics Highlights Updated Miv-cel Data at EULAR Demonstrating Substantial Reduction in Disease Activity in ACPA-Positive, Treatment Refractory Rheumatoid Arthritis

Indeterminate GlobeNewswire

Jun. 3, 2026

Terra Balcanica Obtains Exploration Licence in Bosnia-Herzegovina

Indeterminate GlobeNewswire

Jun. 3, 2026

Angelini Ventures Marks First Portfolio Company Exit as ResMed Acquires Noctrix Health for $340 million

Indeterminate GlobeNewswire

Jun. 3, 2026

Koryx Copper Provides Project Development Update for the Haib Copper Project in Southern Namibia

Indeterminate GlobeNewswire

Jun. 3, 2026

Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 3, 2026

Cabaletta Bio Announces New Rese-cel Data and Development Updates Across Autoimmune Portfolio, Including Encouraging Early PC-Free Lupus Findings, at EULAR 2026 Congress

Indeterminate GlobeNewswire

Jun. 3, 2026

Cocrystal Pharma Appoints James Sapirstein, Biopharma Industry Leader with Extensive Antiviral Development Experience, as Chief Executive Officer

Indeterminate GlobeNewswire